Skip to main content
Erschienen in: Heart and Vessels 1/2018

03.08.2017 | Original Article

Clinical outcomes of left main crossover stenting for ostial left anterior descending artery acute myocardial infarction

verfasst von: Kei Yamamoto, Kenichi Sakakura, Naoyuki Akashi, Yusuke Watanabe, Masamitsu Noguchi, Yousuke Taniguchi, Hiroshi Wada, Shin-ichi Momomura, Hideo Fujita

Erschienen in: Heart and Vessels | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Percutaneous coronary interventions to ostial left anterior descending artery (LAD)-acute myocardial infarction (AMI) were challenging, especially in crossover stenting from left main trunk (LMT) to LAD. The clinical outcomes of ostial LAD-AMI that needed crossover stenting were not well investigated. The objective of this study was to compare the clinical outcomes of LMT crossover stenting with those of ostial LAD just proximal (jp) stenting. Between January 2009 and March 2016, 1499 patients were diagnosed as AMI in our institution. Among them, 76 ostial LAD-AMIs were included in this study, and divided into 30 LMT crossover stenting (the crossover group) and 46 jp stenting (the jp stenting group). The primary endpoint was major cardiovascular events (MACE) defined as the composite of cardiac death, acute myocardial infarction (AMI), stent thrombosis (ST), target lesion revascularization (TLR) and target vessel revascularization (TVR). The frequency of MACE was comparable between the 2 groups (16.7% in the crossover group and 21.7% in the jp stenting group, P = 0.587). Similarly, the frequency of cardiac death was comparable between the 2 groups (6.7% in the crossover group and 13.0% in the jp stenting group, P = 0.376). The frequencies of TLR (6.7% in the crossover group and 6.5% in the jp stenting group, P = 0.980) and TVR (10.0% in the crossover group and 8.7% in the jp stenting group, P = 0.848) were not significantly different between the 2 groups. In conclusion, the clinical outcomes of the crossover stenting were comparable to the jp stenting in the stenting strategy for ostial LAD-AMI. LMT-LAD crossover stenting would be the acceptable strategy for ostial LAD-AMI.
Literatur
1.
Zurück zum Zitat Neri R, Migliorini A, Moschi G, Valenti R, Dovellini EV, Antoniucci D (2002) Percutaneous reperfusion of left main coronary disease complicated by acute myocardial infarction. Catheter Cardiovasc Interv 56:31–34CrossRefPubMed Neri R, Migliorini A, Moschi G, Valenti R, Dovellini EV, Antoniucci D (2002) Percutaneous reperfusion of left main coronary disease complicated by acute myocardial infarction. Catheter Cardiovasc Interv 56:31–34CrossRefPubMed
2.
Zurück zum Zitat Sakakura K, Kubo N, Hashimoto S, Ikeda N, Funayama H, Hirahara T, Sugawara Y, Yasu T, Ako J, Kawakami M, Momomura S (2008) Determinants of in-hospital death in left main coronary artery myocardial infarction complicated by cardiogenic shock. J Cardiol 52:24–29CrossRefPubMed Sakakura K, Kubo N, Hashimoto S, Ikeda N, Funayama H, Hirahara T, Sugawara Y, Yasu T, Ako J, Kawakami M, Momomura S (2008) Determinants of in-hospital death in left main coronary artery myocardial infarction complicated by cardiogenic shock. J Cardiol 52:24–29CrossRefPubMed
3.
Zurück zum Zitat Brener SJ, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink JH, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone GW (2013) Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI) trial. Am Heart J 166:64–70CrossRefPubMed Brener SJ, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink JH, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone GW (2013) Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI) trial. Am Heart J 166:64–70CrossRefPubMed
4.
Zurück zum Zitat Chang K, Koh YS, Jeong SH, Lee JM, Her SH, Park HJ, Kim PJ, Kim YH, Chung WS, Yim HW, Park SJ, Seung KB (2012) Long-term outcomes of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary bifurcation disease in the drug-eluting stent era. Heart (British Cardiac Society) 98:799–805 Chang K, Koh YS, Jeong SH, Lee JM, Her SH, Park HJ, Kim PJ, Kim YH, Chung WS, Yim HW, Park SJ, Seung KB (2012) Long-term outcomes of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary bifurcation disease in the drug-eluting stent era. Heart (British Cardiac Society) 98:799–805
5.
Zurück zum Zitat Yamane M, Inoue S, Yamane A, Kinebuchi O, Yokozuka H (2005) Primary stenting for left-main shock syndrome. Eurointervention 1:198–203PubMed Yamane M, Inoue S, Yamane A, Kinebuchi O, Yokozuka H (2005) Primary stenting for left-main shock syndrome. Eurointervention 1:198–203PubMed
6.
Zurück zum Zitat Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130CrossRefPubMed Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130CrossRefPubMed
7.
Zurück zum Zitat Watanabe Y, Sakakura K, Taniguchi Y, Adachi Y, Noguchi M, Akashi N, Wada H, Momomura SI, Fujita H (2016) Determinants of in-hospital death in acute myocardial infarction with triple vessel disease. Int Heart J 57:697–704CrossRefPubMed Watanabe Y, Sakakura K, Taniguchi Y, Adachi Y, Noguchi M, Akashi N, Wada H, Momomura SI, Fujita H (2016) Determinants of in-hospital death in acute myocardial infarction with triple vessel disease. Int Heart J 57:697–704CrossRefPubMed
8.
Zurück zum Zitat National Heart, Lung, and Blood Institute Coronary Artery Surgery Study Group (1981) National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography. Circulation 63(6 Pt 2):I1–I81 National Heart, Lung, and Blood Institute Coronary Artery Surgery Study Group (1981) National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography. Circulation 63(6 Pt 2):I1–I81
9.
Zurück zum Zitat Kishi K, Kimura T, Morimoto T, Namura M, Muramatsu T, Nishikawa H, Hiasa Y, Isshiki T, Nobuyoshi M, Mitsudo K, j-Cypher Registry I (2011) Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: 3-year outcome from the j-Cypher Registry. Circ Cardiovasc Interv 4:362–370CrossRefPubMed Kishi K, Kimura T, Morimoto T, Namura M, Muramatsu T, Nishikawa H, Hiasa Y, Isshiki T, Nobuyoshi M, Mitsudo K, j-Cypher Registry I (2011) Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: 3-year outcome from the j-Cypher Registry. Circ Cardiovasc Interv 4:362–370CrossRefPubMed
10.
Zurück zum Zitat Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research C (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351CrossRefPubMed Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research C (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351CrossRefPubMed
11.
Zurück zum Zitat Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW (2005) Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol 45:1193–1200CrossRefPubMed Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW (2005) Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol 45:1193–1200CrossRefPubMed
12.
Zurück zum Zitat Murasato Y, Yamamoto T, Suematsu Y (2011) Potential risk of provisional stenting in left main coronary artery bifurcation in multivessel-related acute coronary syndrome. Catheter Cardiovasc Interv 78:737–744CrossRefPubMed Murasato Y, Yamamoto T, Suematsu Y (2011) Potential risk of provisional stenting in left main coronary artery bifurcation in multivessel-related acute coronary syndrome. Catheter Cardiovasc Interv 78:737–744CrossRefPubMed
13.
Zurück zum Zitat Watanabe Y, Takagi K, Nakamura S (2015) Acute and chronic total occlusion of the left circumflex artery following unprotected left main stenting: two contrasting cases. Coron Artery Dis 26:548–550CrossRefPubMed Watanabe Y, Takagi K, Nakamura S (2015) Acute and chronic total occlusion of the left circumflex artery following unprotected left main stenting: two contrasting cases. Coron Artery Dis 26:548–550CrossRefPubMed
14.
Zurück zum Zitat Medina A, Suarez de Lezo J, Pan M (2006) A new classification of coronary bifurcation lesions. Rev Esp Cardiol 59:183CrossRefPubMed Medina A, Suarez de Lezo J, Pan M (2006) A new classification of coronary bifurcation lesions. Rev Esp Cardiol 59:183CrossRefPubMed
15.
Zurück zum Zitat Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH, Bresnahan JF, Grill DE, Holmes DR Jr (2000) Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 35:929–936CrossRefPubMed Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH, Bresnahan JF, Grill DE, Holmes DR Jr (2000) Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 35:929–936CrossRefPubMed
16.
Zurück zum Zitat Seo JB, Shin DH, Park KW, Koo BK, Gwon HC, Jeong MH, Seong IW, Rha SW, Yang JY, Park SJ, Yoon JH, Han KR, Park JS, Hur SH, Tahk SJ, Kim HS (2016) Predictors for side branch failure during provisional strategy of coronary intervention for bifurcation lesions (from the Korean Bifurcation Registry). Am J Cardiol 118:797–803CrossRefPubMed Seo JB, Shin DH, Park KW, Koo BK, Gwon HC, Jeong MH, Seong IW, Rha SW, Yang JY, Park SJ, Yoon JH, Han KR, Park JS, Hur SH, Tahk SJ, Kim HS (2016) Predictors for side branch failure during provisional strategy of coronary intervention for bifurcation lesions (from the Korean Bifurcation Registry). Am J Cardiol 118:797–803CrossRefPubMed
17.
Zurück zum Zitat Pfahl K, Boudoulas KD (2014) Left main coronary artery stent thrombosis: a challenging case. Am J Med 127:e9–e10CrossRefPubMed Pfahl K, Boudoulas KD (2014) Left main coronary artery stent thrombosis: a challenging case. Am J Med 127:e9–e10CrossRefPubMed
18.
Zurück zum Zitat de la Torre Hernandez JM, Baz Alonso JA, Gomez Hospital JA, Alfonso Manterola F, Garcia Camarero T, Gimeno de Carlos F, Roura Ferrer G, Recalde AS, Martinez-Luengas IL, Gomez Lara J, Hernandez HF, Perez-Vizcayno MJ, Cequier Fillat A, Perez de Prado A, Gonzalez-Trevilla AA, Jimenez Navarro MF, Mauri Ferre J, Fernandez Diaz JA, Pinar Bermudez E, Zueco Gil J, Study I-T-IS (2014) Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC Cardiovasc Interv 7:244–254CrossRefPubMed de la Torre Hernandez JM, Baz Alonso JA, Gomez Hospital JA, Alfonso Manterola F, Garcia Camarero T, Gimeno de Carlos F, Roura Ferrer G, Recalde AS, Martinez-Luengas IL, Gomez Lara J, Hernandez HF, Perez-Vizcayno MJ, Cequier Fillat A, Perez de Prado A, Gonzalez-Trevilla AA, Jimenez Navarro MF, Mauri Ferre J, Fernandez Diaz JA, Pinar Bermudez E, Zueco Gil J, Study I-T-IS (2014) Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC Cardiovasc Interv 7:244–254CrossRefPubMed
19.
Zurück zum Zitat Buchanan GL, Chieffo A, Bernelli C, Montorfano M, Carlino M, Latib A, Figini F, Giannini F, Durante A, Ielasi A, Castelli A, Colombo A (2013) Two-year outcomes following unprotected left main stenting with first vs. new-generation drug-eluting stents: the FINE registry. Eurointervention 9:809–816CrossRefPubMed Buchanan GL, Chieffo A, Bernelli C, Montorfano M, Carlino M, Latib A, Figini F, Giannini F, Durante A, Ielasi A, Castelli A, Colombo A (2013) Two-year outcomes following unprotected left main stenting with first vs. new-generation drug-eluting stents: the FINE registry. Eurointervention 9:809–816CrossRefPubMed
20.
Zurück zum Zitat Higami H, Shiomi H, Niki S, Tazaki J, Imai M, Saito N, Makiyama T, Shizuta S, Shioi T, Ono K, Kimura T (2015) Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease. Cardiovasc Interv Ther 30:189–197CrossRefPubMed Higami H, Shiomi H, Niki S, Tazaki J, Imai M, Saito N, Makiyama T, Shizuta S, Shioi T, Ono K, Kimura T (2015) Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease. Cardiovasc Interv Ther 30:189–197CrossRefPubMed
21.
Zurück zum Zitat Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED, Campbell S, Storey RF, Gunn J (2013) Incidence and predictors of stent thrombosis: a single-centre study of 5833 consecutive patients undergoing coronary artery stenting. Eurointervention 9:62–69CrossRefPubMed Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED, Campbell S, Storey RF, Gunn J (2013) Incidence and predictors of stent thrombosis: a single-centre study of 5833 consecutive patients undergoing coronary artery stenting. Eurointervention 9:62–69CrossRefPubMed
22.
Zurück zum Zitat Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T (2013) Management and 2-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J 77:934–943CrossRefPubMed Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T (2013) Management and 2-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J 77:934–943CrossRefPubMed
23.
Zurück zum Zitat Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, Corbalan R, Chierchia SL, Boland JB, Simoons ML, Califf RM, Topol EJ, Harrington RA (2000) Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy. JAMA 283:347–353CrossRefPubMed Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, Corbalan R, Chierchia SL, Boland JB, Simoons ML, Califf RM, Topol EJ, Harrington RA (2000) Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy. JAMA 283:347–353CrossRefPubMed
24.
Zurück zum Zitat Badheka AO, Patel NJ, Grover P, Singh V, Patel N, Arora S, Chothani A, Mehta K, Deshmukh A, Savani GT, Patel A, Panaich SS, Shah N, Rathod A, Brown M, Mohamad T, Tamburrino FV, Kar S, Makkar R, O’Neill WW, De Marchena E, Schreiber T, Grines CL, Rihal CS, Cohen MG (2014) Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005–2009). Circulation 130:1392–1406CrossRefPubMed Badheka AO, Patel NJ, Grover P, Singh V, Patel N, Arora S, Chothani A, Mehta K, Deshmukh A, Savani GT, Patel A, Panaich SS, Shah N, Rathod A, Brown M, Mohamad T, Tamburrino FV, Kar S, Makkar R, O’Neill WW, De Marchena E, Schreiber T, Grines CL, Rihal CS, Cohen MG (2014) Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005–2009). Circulation 130:1392–1406CrossRefPubMed
25.
Zurück zum Zitat Xu B, Redfors B, Yang Y, Qiao S, Wu Y, Chen J, Liu H, Chen J, Xu L, Zhao Y, Guan C, Gao R, Genereux P (2016) Impact of operator experience and volume on outcomes after left main coronary artery percutaneous coronary intervention. JACC Cardiovasc Interv 9:2086–2093CrossRefPubMed Xu B, Redfors B, Yang Y, Qiao S, Wu Y, Chen J, Liu H, Chen J, Xu L, Zhao Y, Guan C, Gao R, Genereux P (2016) Impact of operator experience and volume on outcomes after left main coronary artery percutaneous coronary intervention. JACC Cardiovasc Interv 9:2086–2093CrossRefPubMed
Metadaten
Titel
Clinical outcomes of left main crossover stenting for ostial left anterior descending artery acute myocardial infarction
verfasst von
Kei Yamamoto
Kenichi Sakakura
Naoyuki Akashi
Yusuke Watanabe
Masamitsu Noguchi
Yousuke Taniguchi
Hiroshi Wada
Shin-ichi Momomura
Hideo Fujita
Publikationsdatum
03.08.2017
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 1/2018
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-017-1033-0

Weitere Artikel der Ausgabe 1/2018

Heart and Vessels 1/2018 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.